The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell transplant–associated thrombotic microangiopathy (TA-TMA) in adults and children aged ...
Stay updated with the latest news on Times of India. Get all the trending City News, India News, Business News, and Sports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback